首页 | 本学科首页   官方微博 | 高级检索  
   检索      


The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax
Authors:Kenneth Mark Coggeshall  Florea Lupu  Jimmy Ballard  Jordan P Metcalf  Judith A James  Darise Farris  Shinichiro Kurosawa
Institution:1. Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, , Oklahoma City, OK, USA;2. Cardiovascular Biology Program, Oklahoma Medical Research Foundation, , Oklahoma City, OK, USA;3. The Department of Microbiology, University of Oklahoma Health Sciences Center, , Oklahoma City, OK, USA;4. The Department of Medicine, University of Oklahoma Health Sciences Center, , Oklahoma City, OK, USA;5. Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, , Oklahoma City, OK, USA;6. Department of Pathology & Laboratory Medicine, Boston University School of Medicine, , Boston, MA, USA
Abstract:Inhalation anthrax is often described as a toxin‐mediated disease. However, the toxaemia model does not account for the high mortality of inhalation anthrax relative to other forms of the disease or for the pathology present in inhalation anthrax. Patients with inhalation anthrax consistently show extreme bacteraemia and, in contrast to animals challenged with toxin, signs of sepsis. Rather than toxaemia, we propose that death in inhalation anthrax results from an overwhelming bacteraemia that leads to severe sepsis. According to our model, the central role of anthrax toxin is to permit the vegetative bacteria to escape immune detection. Other forms of B. anthracis infection have lower mortality because their overt symptoms early in the course of disease cause patients to seek medical care at a time when the infection and its sequelae can still be reversed by antibiotics. Thus, the sepsis model explains key features of inhalation anthrax and may offer a more complete understanding of disease pathology for researchers as well as those involved in the care of patients.
Keywords:Sepsis  anthrax  lethal factor  oedema factor  disseminated intravascular coagulation  Gram‐positive
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号